-
EP1115876
European procedure
Extract from the Register of European Patents
EP Citations: EP1115876
| Cited in | International search | Type: | Patent literature | Publication No.: | EP0533006
[X] (HOFFMANN LA ROCHE [CH]) [X] 1,2,4,10-25 * examples 12,13; claims 1,3,5,8-10 *; | Type: | Patent literature | Publication No.: | WO9318047
[A] (LUDWIG INST CANCER RES [US]) [A] * the whole document *; | Type: | Patent literature | Publication No.: | WO9319163
[X] (YEDA RES & DEV [IL]) [X] 1,2,4,10-25 * abstract * * page 7, line 8 - page 8, line 1 * * page 8, line 31 - line 36 * * page 17, line 21 - line 24; claims 1,12,16 *; | Type: | Patent literature | Publication No.: | WO9319777
[X] (IMMUNEX CORP [US]) [X] 1-4,10-25 * claims;; examples 12,13 *; | Type: | Patent literature | Publication No.: | WO9422914
[X] (HUTCHINSON FRED CANCER RES [US], et al) [X] 1-4,9-25 * the whole document *; | Type: | Patent literature | Publication No.: | WO9506737
[X] (PRENDERGAST KENNETH FRANCIS [GB]) [X] 1-4,10-25 * see seq.ID.16 and the claims *; | Type: | Patent literature | Publication No.: | WO9510611
[A] (HARVARD COLLEGE [US]) [A] * example 1; claims 5,13 *; | Type: | Patent literature | Publication No.: | WO9604389
[A] (REGENERON PHARMA [US]) [A] * the whole document *; | Type: | Patent literature | Publication No.: | WO9611213
[XD] (AMGEN BOULDER INC [US]) [XD] 1-4,9-25 * the whole document *; | Type: | Patent literature | Publication No.: | WO9623881
[X] (CELL GENESYS INC [US]) [X] 1-4,9-25 * page 16, line 14 - page 19, line 25 * * page 47, line 5 - page 48, line 13 * * page 51, line 12 - page 52, line 3 * * page 54, line 31 - page 55, line 17 * * page 58, line 10 - page 59, line 3 * * page 61, line 33 - page 62, line 20 * * page 65, line 10 - page 66, line 3 * * page 69, line 5 - line 25 * * page 72, line 4 - line 22 * * page 75, line 10 - page 76, line 3; figure 5; claims 1,3,4,6,11,12,14,15,17,23,25,26,ETC.. *; | Type: | Patent literature | Publication No.: | WO9635783
[X] (CHIRON CORP [US], et al) [X] 1,2,4,10-25 * claims 4,5 *; | Type: | Patent literature | Publication No.: | WO9715669
[X] (US HEALTH [US]) [X] 1-4,10-25 * page 18, line 27 - line 34; claims 12,16,28 *; | Type: | Patent literature | Publication No.: | WO9723613
[A] (CELLTECH THERAPEUTICS LTD [GB], et al) [A] * page 5, line 32 - page 6, line 30 * * page 7, line 26 - line 34; figures 14-17; claim 26 *; | Type: | Patent literature | Publication No.: | WO9731946
[X] (GENETICS INST [US]) [X] 1,2,4,10-25 * example 4; claims 11,27,28 *; | Type: | Patent literature | Publication No.: | WO9802558
[A] (UNIV NEW JERSEY MED [US]) [A] * page 8, line 25 - page 10, line 5; figures 1,7,10,17 * * page 25, line 8 - page 28, line 7; claims 1,7-9 *; | Type: | Patent literature | Publication No.: | EP0835939
[X] (HOECHST AG [DE], et al) [X] 1,2,4,9-25 * example 2; claims 8,9,17,21 *; | Type: | Patent literature | Publication No.: | EP0864585
[A] (HAYASHIBARA BIOCHEM LAB [JP]) [A] * the whole document *; | Type: | Patent literature | Publication No.: | WO9937772
[PX] (IMMUNEX CORP [US], et al) [PX] 1-3,9-18,25 * page 3, line 11 - line 26 * * page 6, line 7 - line 9; examples 1,3,4 * * page 8, line 22 - line 34 ** page 10, line 7 - line 15 *; | Type: | Non-patent literature | Publication information: | [X] - SEIPELT I ET AL, "Overexpression, purification, and use of a soluble human interleukin-4 receptor alpha-chain/Ig gamma 1 fusion protein for ligand binding studies. Characterization of ligand binding to soluble IL-4 receptor alpha-chain by surface plasmon resonance measurements and by microtiter-plate-based ELISA with", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,US,ACADEMIC PRESS INC. ORLANDO, FL, (19971020), vol. 239, ISSN 0006-291X, pages 534 - 542, XP002105430 [X] 1,2,4,10-18,23,25 * the whole document * | DOI: | http://dx.doi.org/10.1006/bbrc.1997.7509 | Type: | Non-patent literature | Publication information: | [A] - DUSCHL A ET AL, "TRANSMEMBRANE AND INTRACELLULAR SIGNALLING BY INTERLEUKIN - 4: RECEPTOR DIMERIZATION AND BEYOND", EUROPEAN CYTOKINE NETWORK, (1996), XP002061702 [A] * figure 4 * | Type: | Non-patent literature | Publication information: | [PX] - STAHL, N. ET AL., "Cytokine traps: heteromeric receptor-based protein therapeutics that function as high-affinity blockers of cytokine action.", FASEB JOURNAL, (19990423), vol. 13, no. 7, pages A1585 - Abstr.1457, XP002133324 [PX] 1-4,10-14 * the whole document * |